Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Efficacy of a Persian Herbal Medicine Compound on Coronavirus Disease 2019 (Covid-19): A Randomized Clinical Trial Publisher



Setayesh M1 ; Karimi M2 ; Zargaran A3 ; Abousaidi H4 ; Shahesmaeili A5 ; Amiri F6 ; Hasheminasab FS7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Traditional Medicine, School of Persian medicine, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Traditional Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health Kerman University of Medical Sciences, Kerman, Iran
  6. 6. Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
  7. 7. Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

Source: Integrative Medicine Research Published:2022


Abstract

Background: The global attention to the capacities of traditional medicine for alleviating the clinical manifestations of COVID-19 has been growing. The present trial aimed to evaluate the efficacy and safety of a Persian herbal medicine formula among patients with COVID-19. Methods: The present trial was conducted in Afzalipour hospital, Kerman, Iran, from June to September 2020. Hospitalized COVID-19 patients were randomly divided into intervention (Persian herbal medicine formula + routine treatment) or control (only routine treatment) groups. The intervention group received both capsule number 1 and 2 every 8 hours for 7 days. Capsule number 1 contained extract of the Glycyrrhiza glabra, Punica granatum, and Rheum palmatum, and the second capsule was filled by Nigella sativa powder. Participants were followed up to 7 days. The primary outcome was the number of hospitalization days, while cough, fever, and respiratory rate, days on oxygen (O2) therapy, and mortality rate were considered as the secondary outcomes. Results: Eighty-two patients were enrolled to the study, while 79 cases completed the trial and their data were analyzed (mean age: 59.1 ± 17.1 years). Based on the results, the Persian medicine formula decreased the mean hospitalization days, so that the mean difference of length of hospitalization as primary outcome was 2.95 ± 0.43 days. A significant clinical improvement was observed regarding dyspnea, need for O2) therapy, and respiratory rate in the intervention group. No adverse effects were reported. Conclusion: The present study supported the use of the Persian medicine formula as an adjuvant therapy for hospitalized COVID-19 patients. Study registration: Iranian Registry of Clinical Trials (www.irct.ir): IRCT20200330046899N1. Study registration: Iranian Registry of Clinical Trials (www.irct.ir): IRCT20200330046899N1. © 2022
Related Docs
1. Efficacy of Persian Medicine Herbal Formulations (Capsules And Decoction) Compared to Standard Care in Patients With Covid-19, a Multicenter Open-Labeled, Randomized, Controlled Clinical Trial, Phytotherapy Research (2021)
2. The Effect of a Hydrogel Made by Nigella Sativa L. on Acne Vulgaris: A Randomized Double-Blind Clinical Trial, Phytotherapy Research (2020)
3. Phytopharmaceuticals Mediated Furin and Tmprss2 Receptor Blocking: Can It Be a Potential Therapeutic Option for Covid-19?, Phytomedicine (2021)
4. Efficacy and Safety of Novel Herbal Tablets in Covid-19 Patients in Hospital Stay Days, Icu Admission and Mortality Rate Thereof: An Ppen-Label, Single-Blind Randomized Clinical Trial, Jundishapur Journal of Natural Pharmaceutical Products (2022)
5. The Effects of a Melissa Officinalis L. Based Product on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus: A Randomized Double-Blinded Controlled Clinical Trial, Journal of Complementary and Integrative Medicine (2020)
Experts (# of related papers)
View all Related Experts
Arman Zargaran (2)
Nima Rezaei (1)